INS-PRESCRIPTION DRUG BENEFITS Senate SponsorsSen. Don Harmon-Laura Fine and Adriane Johnson-John Connor 1/10/2023SenateSession Sine Die 215 ILCS 134/45.3 newAmends the Managed Care Reform and Patient Rights Act. Requires health insurance carriers that provide coverage for prescription drugs to ensure that, within service areas and levels of coverage specified by federal law, at least half of individual and group plans meet one or more of the following criteria: apply a pre-deductible and flat-dollar copayment structure to the entire drug benefit, limit a beneficiary's monthly out-of-pocket financial responsibility for prescription drugs to a specified amount, or limit a beneficiary's annual out-of-pocket financial responsibility for prescription drugs to a specified amount. Provides that all plans for prescription drugs offered under the amendatory Act must be clearly and appropriately named, marketed in the same manner as other plans offered by the health insurance carrier, and offered for purchase to any individual and group plan sponsor. Effective January 1, 2022. 2/19/2021SenateFiled with Secretary by Sen. Scott M. Bennett 2/19/2021SenateFirst Reading 2/19/2021SenateReferred to Assignments 2/24/2021SenateAssigned to Insurance 2/25/2021SenateAdded as Chief Co-Sponsor Sen. Laura Fine 3/23/2021SenateAdded as Co-Sponsor Sen. Adriane Johnson 4/16/2021SenateAdded as Chief Co-Sponsor Sen. John Connor 4/16/2021SenateRule 3-9(a) / Re-referred to Assignments 12/22/2022SenateChief Sponsor Changed to Sen. Don Harmon 1/10/2023SenateSession Sine Die